| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 162,9 k € | +22.3% | 133,2 k € | +13.5% | 117,4 k € | |
| EBITDA | 147,2 k € | +14.8% | 128,3 k € | +9.4% | 117,2 k € | |
| Operating profit | 95,6 k € | -15.3% | 112,8 k € | +5.9% | 106,5 k € | |
| Profit/loss | 65,8 k € | -16.1% | 78,4 k € | -5.4% | 82,8 k € | |
| Equity | 70,8 k € | -57.4% | 166,2 k € | +89.2% | 87,8 k € | |
| Total assets | 485,4 k € | +65.2% | 293,9 k € | +35.9% | 216,3 k € | |
| Cash | 160,5 k € | +31.8% | 121,8 k € | +96.1% | 62,1 k € | |
| Debts | 414,3 k € | +224.4% | 127,7 k € | -0.6% | 128,4 k € | |
Source: Belgian Official Gazette
Private limited company profitable and well capitalised. Cash position rising (+31.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Vcoptic is a Private limited company incorporated in 2022. Its main activity is: Retail sale of medical and orthopaedic goods in specialised stores. Its registered office is in Walcourt.